Ads
related to: stryker stock price forecastwallstreetwatchdogs.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure raises a concern.
Stryker (NYSE:SYK) has had a great run on the share market with its stock up by a significant 14% over the last three...
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Need help? Call us! 800-290-4726 Login / Join. Mail
For premium support please call: 800-290-4726 more ways to reach us
Stryker now expects organic net sales growth for 2024 to be in the range of 8.5% to 9.5%, compared with its earlier projected range of 7.5% to 9%. Stryker lifts 2024 profit forecast on strong ...